|
 |
| home > pmps > autumn 2003 > new orbital welding documentation method improves accuracy for inspections and leads to lower cost per weld |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Orbital tube welding is the recommended method of fabrication for bioprocessing equipment. It has not changed significantly since the 1960s when it was introduced into the aerospace industry. Operators still use the gas tungsten arc welding (GTAW) process and orbit or rotate an electrode around a fixtured weld joint with a predetermined set of weld parameters programmed into the power supply (1). While the orbital welding process itself has remained largely unchanged, advancements in welding system technology have greatly improved weld documentation. For example, today's orbital welding equipment utilises microprocessor technology that provides interface capabilities, enabling data to be transferred to other computers for analysing and customising reports that document quality, cost of welds and other critical information. These types of advancements address increasing requirements for bioprocessing systems.
Weld documentation provides full traceability for all materials and procedures used for construction and maintenance of bioprocessing systems. Such documentation must provide the necessary verification that each weld meets the weld acceptance criteria as defined by the weld specification. In the event of a problem with a system, such as contamination, the documentation provides a means to go back and review each welded connection as part of the effort to track down and find the source.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
EMBALLAGE 2008. World Packaging Exhibition
16-21 November 2008, Paris-Nord Villepinte - France
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
